Remove companies sarepta-therapeutics-inc
article thumbnail

District Court Grants Summary Judgment and Invalidates Patent in REGENXBIO v. Sarepta Litigation

LexBlog IP

On January 5, 2024, in litigation between REGENXBIO and Sarepta Therapeutics, Judge Richard Andrews of the U.S. District Court for the District of Delaware District Court granted summary judgment for Sarepta and ruled that University of Pennsylvania’s (“Penn”) U.S. last year is ongoing. § 101. Stay tuned.

article thumbnail

Erie Doctrine, General Principles, and Running-Out the Clock

Patently-O

Sarepta Therapeutics, Inc. After a failed negotiation, Sarepta petitioned for Inter Partes Review of Nippon Shinyaku’s patents. Sarepta has now petitioned for en banc review: asking two procedural questions, including one on the Erie Doctrine. Webasto Sunroofs, Inc., Nippon Shinyaku Co. 2d 113 (Del.

article thumbnail

2021 Post-Grant Report

Fish & Richardson Trademark & Copyright Thoughts

Arthrex, Inc., Sotera Wireless, Inc. In Sotera Wireless, Inc. Reynolds Vapor Company v. The most active petitioners in 2021 were Sarepta Therapeutics, Inc., The most active patent owners in 2021 were Ravgen, Inc., Regeneron Pharmaceuticals, Inc., and Celltrion, Inc. 1970 (2021).